INSIGHTS ON DRUG DEVELOPMENT
-
![Building-Better-Degraders-Targeted-Protein-Degradation-Webinar_MilliporeSigma]( "Building Better Degraders: Targeted Protein Degradation Partners")
Building Better Degraders: Targeted Protein Degradation PartnersLearn from industry experts about the latest advances in chemical building blocks for protein degradation, including warheads, linkers, and ligands, and their role in constructing superior degrades.
-
![Collaborating For A Sustainable Future Advancing Process Intensification Together]( "Collaborating For A Sustainable Future")
Collaborating For A Sustainable FutureExplore how cross-industry partnerships are driving sustainable process intensification to enable faster innovation, reduced waste, and long-term progress through shared goals and scalable solutions.
-
![Pharmaceutical Characterization With The New Multi-Sample Discovery X3 DSC]( "Reach Development Goals Faster With Multi-Sample Workflow Technology")
Reach Development Goals Faster With Multi-Sample Workflow TechnologyExplore the use of Differential Scanning Calorimetry (DSC) multi-sample technology to analyze a variety of pharmaceutical materials and understand critical information for advancing pharma development.
-
![Douglas CDMO - Resized]( "How A Privately Owned CDMO Is Transforming Client Expectations")
How A Privately Owned CDMO Is Transforming Client ExpectationsFinding a partner with flexible services and a strong emphasis on building long-term client relationships can help ensure success for your pharmaceutical product.
-
Expanding Opportunities For Inhaled Drug Delivery7/11/2025
Review the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.
-
Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS7/29/2025
Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.
-
Success Story: Increased Productivity With Concentrated Fed-Batch6/30/2025
Discover how a leading biopharma company boosted flexibility and quadrupled productivity by implementing a concentrated fed-batch process in a single-use facility.
-
Collaboration An Untapped Fuel For Driving Biopharma R&D10/20/2025
Biopharma’s future depends on collaboration. Discover how cross-industry partnerships and shared resources can accelerate innovation, overcome talent gaps, and strengthen the global R&D ecosystem.
-
Spatial Biology: Learning The Landscape1/8/2024
Biological research is changing with a growing understanding of spatial biology, including the organization and interaction of molecules, cells, and tissues in their native spatial context.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-648181930-viral-development-vaccine-lab]( "Peptide Crystallization")
Cambrex’s understanding of crystal formation and thermodynamics allows us to develop custom, scalable crystallization processes for peptides. We leverage the right tools with the best experts to bridge success from the bench to the plant.
-
![iStock-1319077865-lab-team-computer-research]( "Our Science-Forward Approach To API Development, Manufacturing")
Our highly skilled team of chemists and process engineers, combined with a science-driven project management approach, ensures seamless execution at every stage.
-
![leica-microsystems-cell-dive-hero]( "Transforming Tissue Research With Open Multiplexing")
Cell DIVE Multiplex Imaging Solution
What if every scientist could map normal and diseased tissue by cell type, biomarker profile, and specific features?
Cell DIVE is a precise, open multiplexing solution that lets your research dictate the level of automation required, which antibodies to use, how to build your antibody panel, and more.
-
![GettyImages-1275317360-lab-cell-gene-research-scientist-development-discovery]( "Biocatalysis For Cost-Efficient, Environmentally Friendly Manufacturing")
Biocatalysis enables cost efficient and environmentally friendly manufacturing through enzymatic synthesis and provides pure -regio, chemo- and enantioselective compounds when compared to traditional chemical synthesis.
-
![Factory Cleanroom GettyImages-1294339670]( "Comprehensive ADC And Bioconjugation Services For Targeted Therapies")
Explore end-to-end services offered by a trusted CDMO partner with more than 15 years of industry-leading experience in conjugation and purpose-built manufacturing facilities.
